Hypofractionated 3D-Conformal RT

Shorter Radiation Course Stops Cancer Growth in High-risk Prostate Cancer Patients

Hypofractionated radiation treatment, a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy, is significantly more effective than the older method in stopping cancer growth in high risk patients and causes no increase in negative side effects, an Italian clinical trial shows.

Androgen Blockade for Prostate Cancer May Not Cause Excess Cardiac Deaths

Other adverse effects remain, requiring careful balancing of benefits with risks

Treating prostate cancer patients with drugs that block male hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. But the treatment does increase risks of diabetes and heart disease. How can this outcome hold true?